Chemfab Alkalis Limited — Board Meeting, 12-02-2026: Outcome of Board Meeting
12-02-2026 | 10:05 am
12-02-2026 | 10:05 am
Chemfab Alkalis' Board approved consolidated results for Q3 FY26 and nine months. Revenue from operations was ₹68.14 Cr, with a net loss of ₹4.45 Cr for the quarter. The company also allotted 10,000 shares via ESOS.
No comments yet. Be the first to comment!
